OrsoBio Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Palo Alto, California, operating in the biotechnology research industry. The company focuses on developing therapies for severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. It has four programs in clinical and preclinical development with first-in-class compounds targeting central energy metabolism pathways. OrsoBio's team size is in the 11-50 employee range. The company has raised capital in multiple rounds, including a Series A in 2023 and a Series B in 2024. More information is available on its website at https://orsobio.com.